Choong-jae Lee
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Dysadherin/YAP axis fuels stem plasticity and immune escape in liver cancer.
Journal: Signal transduction and targeted therapy
Published: July 09, 2025
The dysadherin/carbonic anhydrase 9 axis shapes an acidic tumor microenvironment to promote colorectal cancer progression.
Journal: Signal transduction and targeted therapy
Published: April 24, 2025
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression.
Journal: Nature communications
Published: February 12, 2024
The dysadherin/FAK axis promotes individual cell migration in colon cancer.
Journal: International journal of biological sciences
Published: June 01, 2023
SEC22B inhibition attenuates colorectal cancer aggressiveness and autophagic flux under unfavorable environment.
Journal: Biochemical and biophysical research communications
Published: January 30, 2023
Dysadherin awakens mechanical forces and promotes colorectal cancer progression.
Journal: Theranostics
Published: February 24, 2022
DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
Journal: Theranostics
Published: February 15, 2022
The Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression.
Journal: International journal of molecular sciences
Published: November 09, 2021
Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells.
Journal: Clinical and translational medicine
Published: June 11, 2021
A novel nucleolin-binding peptide for Cancer Theranostics.
Journal: Theranostics
Published: December 30, 2019
Last Updated: 09/26/2026